Skip to main content

Clinical TrialsSearch 1M+ trials from global registries Drug IntelligenceFollow pipelines from discovery to approval

Global ApprovalsTrack regulatory decisions across 12+ agencies

US FDA Drugs EU EMA Drugs Singapore HSA Drugs China NMPA Drugs Australia TGA Drugs Canada HC Drugs Spain CIMA-AEMPS Drugs UK EMC Drugs Saudi SFDA Drugs Malaysia NPRA Drugs Philippines FDA Drugs Kenya PPB Drugs

AI-Powered ResearchDiscover powerful insights with advanced AI analysis tools for clinical trials.Learn more →Premium AccessGet unlimited access to our comprehensive pharmaceutical database and analytics.Subscribe →

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

INFUSOL FS (Sodium Chloride 0.225% w/v Intravenous Infusion BP) - NPRA Drug Approval Details

Approvals/NPRA/INFUSOL FS (Sodium Chloride 0.225% w/v Intravenous Infusion BP)

Approved

STANDARD

INFUSOL FS (Sodium Chloride 0.225% w/v Intravenous Infusion BP)

AIN MEDICARE SDN. BHD.🇲🇾 National Pharmaceutical Regulatory Agency

Approval Date: Dec 25, 2025
Approval ID: 45925f04389efc42
Company: AIN MEDICARE SDN. BHD.
Type: Standard

Approval Details

Approval Id: 45925f04389efc42
Drug Approval Npra Name: INFUSOL FS (Sodium Chloride 0.225% w/v Intravenous Infusion BP)
Product Name: INFUSOL FS (Sodium Chloride 0.225% w/v Intravenous Infusion BP)
Registration Number: MAL10070594AZ
Holder Company Name: AIN MEDICARE SDN. BHD.
Holder Address: LOT 4933, 4934 & PT2464, JALAN 6/44, KAW. PERINDUSTRIAN PENGKALAN CHEPA 2, 16100 KOTA BHARU MALAYSIA
Holder Phone: 09-7743388
Manufacturer Company Name: AIN MEDICARE SDN. BHD.
Manufacturer Address: LOT 4933, 4934 & PT2464, JALAN 6/44, KAW. PERINDUSTRIAN PENGKALAN CHEPA 2, 16100 KOTA BHARU MALAYSIA
Source Url: https://quest3plus.bpfk.gov.my/pmo2/detail.php?type=product&id=MAL10070594AZ
Version: 1766641931

Approved

Quick Info

Agency

NPRA

Country

🇲🇾

Approval Date

Dec 25, 2025

Approval ID

45925f04389efc42

Type

Standard

Source

Official Source

Back to NPRA Approvals